View Ligand Pharmaceuticals Incorporated LGND stock quote prices, financial information, real-time forecasts, and company news from CNN.

With combination therapies and multiple treatment options available for patients, nephrology is in a “therapeutic revolution, ...

The Alport syndrome market is expected to witness significant growth over the coming years, driven by advancements in genetic diagnostics, increasing disease awareness, and the introduction ...

Detailed price information for Ultragenyx Pharmaceu (RARE-Q) from The Globe and Mail including charting and trades.

Complete Vera Therapeutics Inc. stock information by Barron's. View real-time VERA stock price and news, along with industry-best analysis.

Travere Therapeutics, Inc. (Nasdaq: TVTX) today announced that on July 10, 2026, the Compensation Committee of its Board of Directors granted inducement equity grants covering an aggregate of 41,600 ...

Food - Allergen - Peanut Distribution: British ColumbiaOntarioQuebec See the affected products and product photos for this ...

June 2026 saw drug development in oncology and neurology continue and biotech deals over small molecules and RNA therapies ...

The first half of 2026 saw the FDA approve 5 notable first-in-class therapies across obesity, AML, kidney disease, hearing loss, and bladder cancer. The first half of 2026 brought a steady stream of ...

Brookdale Senior Living Inc. reported today its occupancy for June 2026.Second Quarter and June 2026 Occupancy ...

Biopharma and med-tech happenings, including deals and partnerships, and other news in brief: Alector, Amgen, Beam, Chemomab, Everest, Fosun, GSK, LG, Niagen, Octave, OTR, Prime, Resmed, Scipher, ...

The U.S. Food and Drug Administration said on Tuesday it had approved Vera Therapeutics' drug ​to treat patients with a ...